Rajendra S. Apte, MD, PhD, and members of the Apte Lab at WashU Medicine John F. Hardesty, MD Department of Ophthalmology and Visual Sciences recently presented their latest research at the 129th Annual Meeting of the Japanese Ophthalmological Society, held April 17-20, 2025, at The Tokyo International Forum in Tokyo.
“It was an honor to present the work from our lab at the 129th Annual Meeting of the Japanese Ophthalmological Society,” said Rajendra Apte, MD, PhD
The conference brought together global leaders in vision science and ophthalmic research to share cutting-edge advancements in the field. Dr. Apte delivered a lecture titled:
“Inflammation and Senescence in AMD Retinal Neurodegeneration” This presentation explored the role of immune-metabolic dysfunction and cellular aging in the progression of age-related macular degeneration (AMD)—a leading cause of vision loss worldwide. His research highlights potential therapeutic avenues to slow or prevent retinal degeneration through targeted interventions.
About the Apte Lab
The Apte Lab investigates the complex interplay between inflammation, metabolism, and neurodegeneration in the retina. Their work bridges foundational science with clinical relevance, aiming to uncover therapeutic targets that could preserve vision and improve quality of life for patients affected by retinal diseases.
Learn more about the lab’s mission and current research at:
https://ophthalmology.wustl.edu/research/labs/apte-lab
About WashU Medicine
WashU Medicine is a global leader in academic medicine, including biomedical research, patient care and educational programs with 2,900 faculty. Its National Institutes of Health (NIH) research funding portfolio is the second largest among U.S. medical schools and has grown 56% in the last seven years. Together with institutional investment, WashU Medicine commits well over $1 billion annually to basic and clinical research innovation and training. Its faculty practice is consistently within the top five in the country, with more than 1,900 faculty physicians practicing at 130 locations and who are also the medical staffs of Barnes-Jewish and St. Louis Children’s hospitals of BJC HealthCare. WashU Medicine has a storied history in MD/PhD training, recently dedicated $100 million to scholarships and curriculum renewal for its medical students, and is home to top-notch training programs in every medical subspecialty as well as physical therapy, occupational therapy, and audiology and communications sciences.